0001415889-23-005565.txt : 20230329 0001415889-23-005565.hdr.sgml : 20230329 20230329162033 ACCESSION NUMBER: 0001415889-23-005565 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230327 FILED AS OF DATE: 20230329 DATE AS OF CHANGE: 20230329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOUTHWELL DAVID P CENTRAL INDEX KEY: 0001251553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23775484 MAIL ADDRESS: STREET 1: C/O INOTEK PHARMACEUTICALS CORPORATION STREET 2: 91 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-03292023_080327.xml X0407 4 2023-03-27 0001070081 PTC THERAPEUTICS, INC. PTCT 0001251553 SOUTHWELL DAVID P C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 true false false false 1 Common Stock 2023-03-27 4 M 0 10000 27.05 A 20500 D Common Stock 2023-03-27 4 S 0 4599 44.7092 D 15901 D Common Stock 2023-03-27 4 S 0 5301 45.4132 D 10600 D Common Stock 2023-03-27 4 S 0 100 46.03 D 10500 D Stock Option (Right to Buy) 27.05 2023-03-27 4 M 0 10000 27.05 D 2024-01-28 Common Stock 10000 0 D Stock Option (Right to Buy) 51 2025-01-02 Common Stock 12000 12000 D Stock Option (Right to Buy) 30.86 2026-01-03 Common Stock 12000 12000 D Stock Option (Right to Buy) 18.01 2028-01-02 Common Stock 14000 14000 D Stock Option (Right to Buy) 33.02 2029-01-02 Common Stock 14000 14000 D Stock Option (Right to Buy) 51.16 2030-01-28 Common Stock 10000 10000 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 10000 10000 D Stock Option (Right to Buy) 38.10 2032-01-06 Common Stock 12000 12000 D Stock Option (Right to Buy) 39.42 2033-01-04 Common Stock 10000 10000 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 24, 2023. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $43.97 to $44.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.00 to $45.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Currently exercisable. This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2023-03-29